Azelis Enters Israel with Orokia Buy
Azelis has agreed to buy Orokia Israel for an undisclosed sum. The purchase will give the Belgian distributor entry to the “highly attractive” Israeli specialty chemicals market. Part of global investment group EQT, Azelis said the takeover of Orokia is consistent with its strategy of complementing organic growth with strategic acquisitions.
Orokia is active in multiple market segments such as agrochemicals, animal nutrition, personal care, food, pharmaceuticals and industrial chemicals. A privately held company, it was founded in July 2005 and purchased the business of Rhodia Israel, the French multi-national’s subsidiary based in Netanya.
“Orokia, and its forerunners, have been present in the Israeli market for almost four decades, during which time the company has built up a strong market presence, counting major global players among the principals represented and serving more than 200 customers,” said Anna Bertona, CEO and president of Azelis EMEA. “This acquisition will bring an abundance of cross-selling opportunities to expand the business with our existing long-standing and trusted partners.”
Azelis did not reveal when it expected the deal to close. All Orokia employees will transfer to the new owner on completion.
The Antwerp-headquartered distributor has announced three other acquisitions so far this year. In May, it agreed to buy PT Primaditha Jaya Mandiri, boosting its position in the Indonesia food market. This was preceded in April by a deal to buy CosBond, a specialty chemicals and food ingredients distributor headquartered in Hong Kong and with facilities in China. In February, Azelis said it would acquire S. Zhaveri Pharmakem, extending its presence in India’s pharmaceutical market
